Given that enzymes like DPP4 and MMP1 play critical roles in immune regulation and metabolic processes, their dysregulation in the context of viral infection could be central to the metabolic disturbances observed in COVID-19 patients. The gene discussed is DPP4; the disease is COVID-19.